Merlintrader’s Daily Briefing

Sunday, July 5, 2026: U.S. equity markets remain closed for the Independence Day weekend and do not reopen until Monday, July 6, so the tape is still anchored to the July 2 close, when the Dow finished at a record above 52,900 while the Nasdaq lagged on semiconductor weakness. The freshest input into Monday is not a stock but a commodity: the eight OPEC+ producers that manage monthly quotas meet today, July 5, with the market expecting another supply increase for August, and their decision lands over the weekend with crude already sitting near multi-month lows. Beyond oil, Friday’s European session had pushed the Stoxx 600 to a fresh 52-week high as the soft June U.S. jobs report kept a rate-relief tone in place. The holiday-shortened week of July 6 to 10 is thin on scheduled data but front-loaded with events: June FOMC minutes on Wednesday, the first drips of Q2 earnings from PepsiCo and Delta, SpaceX’s fast-tracked Nasdaq-100 inclusion before the July 7 open, and a Vera Therapeutics FDA decision also due July 7. With volumes near zero, weekend headlines on oil and rates carry outsized weight into the reopen.

Weekend tape and global markets
  • SPY / QQQ / DIA— With Wall Street shut for the long weekend, the working reference is still Thursday’s July 2 close: the Dow at a record 52,900.07 after a 594-point jump, the S&P 500 roughly flat at 7,483.23 and the Nasdaq down about 0.7% at 26,040.03. The split tape, records at the index level but soft technology leadership, is the setup traders carry into Monday’s reopen.Holiday
  • OPEC+— The eight OPEC+ countries that adjust monthly quotas meet today, July 5, with delegates signaling another output step for August as the group works to unwind the last of the 2023 cuts. Because the decision falls on a weekend with U.S. futures closed, it becomes the single most important swing factor for how energy opens on Monday.Oil
  • Europe— European equities did the heavy lifting while the U.S. was dark: in Friday’s July 3 session the pan-European Stoxx 600 closed at a fresh 52-week high, Germany’s DAX rose about 0.8% to 25,779, France’s CAC 40 added roughly 0.4% to 8,508 and the U.K. FTSE 100 gained 0.3% to 10,679. The softer U.S. labor data continued to underpin the regional bid.Global
  • Payrolls— The June employment report remains the macro anchor: nonfarm payrolls grew just 57,000 against a consensus near 115,000, the jobless rate held at 4.2% only because participation slipped to 61.5%, and April and May were revised down by a combined 74,000. A clearly cooling labor market is the lens for every rate and rotation call into the new week.Macro
  • Semis— Chips are still the market’s soft spot. The semiconductor complex gave back ground through the holiday-shortened week even as the broad indexes printed records, and whether the group stabilizes or extends its pullback is the clearest leadership tell for Monday’s session.Leadership
Rates, oil and cross-asset
  • Fed path— The weak payrolls print pushed the odds of a near-term Fed hike lower and effectively took a July move off the table, but it did not end the debate. Wednesday’s June minutes are now the next read on how policymakers are balancing a softer jobs picture against still-firm inflation.Rates
  • Treasuries— The move in rates was uneven rather than a clean rally: the two-year yield eased toward 4.11% while the long end stayed firm, with the 10-year around 4.48%. Falling front-end hike odds alongside a sticky long end keeps the shape of the curve, not just the Fed, in focus at the reopen.Yields
  • Oil / WTI— WTI crude sat near $67 to $68 a barrel and Brent near $70.6 into the weekend, down sharply over the past two weeks as a geopolitical risk premium bled out. That already-soft backdrop is exactly why today’s OPEC+ decision matters so much for Monday’s energy tape.Energy
  • DXY / Gold— The dollar index eased to about 100.85, down roughly half a percent on the jobs miss, a move that typically supports gold. The firmer long end complicates the clean rate-relief story, so the cleaner Monday confirmation is a contained dollar and stable credit rather than a growth-fear slide.Cross-Asset
U.S.-listed / U.S.-quoted focus

July 2026 Biotech Catalysts

A clean homepage grid focused on tradable U.S. tickers with verified FDA/PDUFA calendar days. Each card links back to Merlintrader coverage, stock hubs or internal ticker pages.

8Tickers
8FDA / PDUFA
Jul 1Updated
FDA / PDUFA Merlintrader key watch U.S. ADR / OTC ADR Private and non-U.S. records excluded
Jul07
PDUFA
$VERA Vera Therapeutics — atacicept Priority Review for adults with IgA nephropathy. One of July’s cleanest renal biotech catalysts. Open Merlintrader hub →
Jul07
PDUFA
$AZN AstraZeneca — Enhertu Priority Review in post-neoadjuvant HER2+ early breast cancer. Large-cap oncology / ADC read-through.
Jul17
PDUFA
$CELC Celcuity — gedatolisib HR+/HER2- PIK3CA wild-type advanced breast cancer. Priority Review oncology catalyst. Open Merlintrader hub →
Jul23
FDA Date
$SNY Sanofi — Sarclisa SC Revised FDA target action date for subcutaneous isatuximab. Multiple myeloma convenience / lifecycle catalyst.
Jul24
PDUFA
$OTSKY Otsuka — centanafadine Priority Review for ADHD in children, adolescents and adults. U.S. OTC/Pink ADR; CNS / ADHD market read-through.
Jul26
PDUFA
$MNKD MannKind — FUROSCIX ReadyFlow ReadyFlow Autoinjector sNDA. Commercial execution catalyst for CHF/CKD edema. Open Merlintrader hub →
Jul29
PDUFA
$OTLK Outlook — ONS-5010 / Lytenava Class 1 review for wet AMD BLA resubmission. Highly sensitive ophthalmology small-cap setup. Open Merlintrader hub →
Jul30
PDUFA
$VTRS Viatris — low-dose estrogen weekly patch 505(b)(2) contraceptive weekly patch. Pipeline milestone, less binary than small-cap biotech.

Merlintrader key watchlist

$VERA — Jul 7 $CELC — Jul 17 $MNKD — Jul 26 $OTLK — Jul 29 $VTRS — Jul 30

Clean-data note

Excluded: private companies, non-U.S.-quoted records, congress-only items, month-only trial estimates, AI-detected records without a confirmed day, already decided events such as $CORT and $LLY imlunestrant (FDA-approved 2025), and non-July records such as $VRDN.

Educational content only — not investment advice. Full catalyst calendar FDA SEC EDGAR

Biotech Catalyst Lookup

Type a ticker to get an AI-generated snapshot of the next catalyst (PDUFA, clinical data, regulatory events) with a link to the primary source.

Disclaimer. This content is for educational and informational purposes only. It is not investment advice and not a recommendation to buy or sell any security, in line with CONSOB (Italy) and SEC (USA) guidance. Data is generated by AI from web sources and may contain errors or be out of date — always verify against the linked primary source. Do your own research and consult a licensed advisor. Full disclaimer: merlintrader.eu/disclaimer.

Avvertenza. Questo contenuto ha finalità esclusivamente didattiche e informative. Non costituisce consulenza finanziaria né una raccomandazione di acquisto o vendita di alcun titolo, in linea con le indicazioni CONSOB (Italia) e SEC (USA). I dati sono generati dall'AI a partire da fonti web e possono contenere errori o non essere aggiornati — verifica sempre rispetto alla fonte primaria collegata. Fai le tue ricerche e consulta un consulente autorizzato. Disclaimer completo: merlintrader.eu/disclaimer.